ProPhase Labs Inc. (PRPH)

2.94 -0.04 (-1.342%)

IEX Real-Time Price

August 17, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 2.98

Price Open 3

Volume: 1,952

Avg Volume: 5,785

Market Cap: 32.72M

P/E Ratio -

52 Wk Range 2.03-6.639


ProPhase Labs up 12% (2018-06-06 13:54 SeekingAlpha)

Thinly traded nano cap ProPhase Labs (NASDAQ: PRPH )is trying to claw back from the recent bout of profit-taking after doubling when it announced a $1 special dividend in a month ago. Shares are up 12% on more than triple normal volume, albeit on turnover of only 150K shareā€¦



Shares Outstanding: 11.13M

Top 15 Institution Percent: 6.40

Price To Sales: 3.13

Price To Book: 0.99

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -6.03

Return On Equity: -6.60

Profit Margin: -4.33

Price History

Beta: 0.03

50-day Moving Avg: 3.01

200-day Moving Avg: 2.80

YTD Change: 31.25

5-day Change: -3.56

1-month Change: -2.97

3-month Change: -40.24

6-month Change: 27.27

1-year Change: 29.52

Revenue Per Share: 0.00

Revenue Per Employee: 0.00


Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -

Company Profile

Name: ProPhase Labs Inc.

Exchange: NASDAQ Capital Market

Industry: Drug Manufacturers

Sector: Healthcare


ProPhase Labs Inc is a manufacturer and distributor of homeopathic and health products. It is also engaged in the research and development of potential over-the-counter drug, natural health products, supplements, personal care & cosmeceutical products.